m6A Regulator and Potential Drug Response
General Information of the m6A Regulator (ID: REG00019)
| Regulator Name | NF-kappa-B-activating protein (NKAP) | ||||
|---|---|---|---|---|---|
| Synonyms |
FLJ22626, MRXSHD
Click to Show/Hide
|
||||
| Gene Name | NKAP | ||||
| Regulator Type | WRITER ERASER READER | ||||
| Regulator Link | Click to View Full Information of This Regulator | ||||
Full List of Target Gene(s) of This m6A Regulator and Corresponding Potential Drug Response(s)
Cystine/glutamate transporter (SLC7A11)
L-glutamic acid [Approved]
| In total 1 mechanisms lead to this potential drug response | ||||
| Response Summary | Cystine/glutamate transporter (SLC7A11) is a therapeutic target for L-glutamic acid. The NF-kappa-B-activating protein (NKAP) has potential in affecting the response of L-glutamic acid through regulating the expression of Cystine/glutamate transporter (SLC7A11). | [1], [2] | ||
SXC-2023 [Phase 2]
| In total 1 mechanisms lead to this potential drug response | ||||
| Response Summary | Cystine/glutamate transporter (SLC7A11) is a therapeutic target for SXC-2023. The NF-kappa-B-activating protein (NKAP) has potential in affecting the response of SXC-2023 through regulating the expression of Cystine/glutamate transporter (SLC7A11). | [1], [3] | ||
References